Yoshino Inoue

469 total citations
21 papers, 218 citations indexed

About

Yoshino Inoue is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, Yoshino Inoue has authored 21 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 9 papers in Immunology and 5 papers in Genetics. Recurrent topics in Yoshino Inoue's work include Systemic Lupus Erythematosus Research (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Yoshino Inoue is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Yoshino Inoue collaborates with scholars based in Japan, United States and France. Yoshino Inoue's co-authors include Shingo Nakayamada, Yoshiya Tanaka, Yusuke Miyazaki, Satoshi Kubo, S. Iwata, Kazuhisa Nakano, Naoaki Ohkubo, Yoshihisa Fujino, Mingzeng Zhang and Takashi Otsuka and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Yoshino Inoue

20 papers receiving 218 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoshino Inoue Japan	9	128	100	36	33	29	21	218
Yukiko Takakuwa Japan	9	104 0.8×	68 0.7×	56 1.6×	25 0.8×	21 0.7×	35	219
Ann Igoe United States	6	162 1.3×	110 1.1×	28 0.8×	70 2.1×	33 1.1×	7	307
Iwona Brzosko Poland	8	146 1.1×	125 1.3×	28 0.8×	30 0.9×	13 0.4×	28	276
Kaoru Takase-Minegishi Japan	7	178 1.4×	57 0.6×	29 0.8×	67 2.0×	49 1.7×	11	287
Francesca Regola Italy	8	97 0.8×	78 0.8×	50 1.4×	11 0.3×	17 0.6×	22	151
María del Mar Ayala Gutiérrez Spain	7	210 1.6×	95 0.9×	23 0.6×	14 0.4×	19 0.7×	12	283
Bettina Bannert Switzerland	7	62 0.5×	35 0.3×	18 0.5×	22 0.7×	21 0.7×	13	158
X Li China	4	141 1.1×	81 0.8×	52 1.4×	23 0.7×	7 0.2×	15	188
L. Nakopoulou Greece	8	202 1.6×	76 0.8×	74 2.1×	72 2.2×	19 0.7×	13	319
Emma Shittu United Kingdom	5	108 0.8×	54 0.5×	16 0.4×	32 1.0×	16 0.6×	6	200

Countries citing papers authored by Yoshino Inoue

Since Specialization

Citations

This map shows the geographic impact of Yoshino Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshino Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshino Inoue more than expected).

Fields of papers citing papers by Yoshino Inoue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshino Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshino Inoue. The network helps show where Yoshino Inoue may publish in the future.

Co-authorship network of co-authors of Yoshino Inoue

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshino Inoue. A scholar is included among the top collaborators of Yoshino Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshino Inoue. Yoshino Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miyazaki, Yusuke, Shingo Nakayamada, Hiroaki Tanaka, et al.. (2025). Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry. RMD Open. 11(1). e004987–e004987. 1 indexed citations

Ohkubo, Naoaki, Shingo Nakayamada, Shunsuke Fukuyo, et al.. (2025). Efficacy and Safety of Rituximab in Connective Tissue Disease‐Associated Thrombotic Thrombocytopenic Purpura/Thrombotic Microangiopathy. International Journal of Rheumatic Diseases. 28(6). e70292–e70292.

Kobayashi, Hiroki, Yusuke Miyazaki, Shingo Nakayamada, et al.. (2024). Predictors of the effectiveness of first-line CTLA4-Ig in patients with RA: the FIRST registry. Lara D. Veeken. 64(5). 2403–2410. 1 indexed citations

Kubo, Satoshi, Yusuke Miyazaki, T Nishino, et al.. (2024). Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness. Annals of the Rheumatic Diseases. 84(2). 210–220. 8 indexed citations

Miyazaki, Yusuke, Shingo Nakayamada, Hiroaki Tanaka, et al.. (2024). Comparison of anti-IL-6 receptor and JAK inhibitors in patients with rheumatoid arthritis from the real-world practice FIRST registry. Lara D. Veeken. 64(4). 1627–1636. 3 indexed citations

Yamamoto, Ryō, et al.. (2023). An elderly man with mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) without neuropsychiatric sequelae. SHILAP Revista de lepidopterología. 11(5). e7219–e7219. 1 indexed citations

Kubo, Satoshi, Yusuke Miyazaki, Koichi Amano, et al.. (2023). Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study. RMD Open. 9(2). e003029–e003029. 5 indexed citations

Miyagawa, Ippei, Shingo Nakayamada, Masanobu Ueno, et al.. (2022). Precision medicine based on the phenotypic differences in peripheral T helper cells in patients with psoriatic arthritis: One year follow-up outcomes. Frontiers in Medicine. 9. 934937–934937. 5 indexed citations

Miyagawa, Ippei, Shingo Nakayamada, Masanobu Ueno, et al.. (2022). Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study. Arthritis Research & Therapy. 24(1). 86–86. 9 indexed citations

10.

Watanabe, Ryu, Megumi Oshima, Norihiro Nishioka, et al.. (2022). Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis. Modern Rheumatology. 33(5). 982–989. 10 indexed citations

11.

Miyazaki, Yusuke, Kazuhisa Nakano, Shingo Nakayamada, et al.. (2021). Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting. Annals of the Rheumatic Diseases. 80(9). 1130–1136. 43 indexed citations

12.

Miyazaki, Yusuke, Shingo Nakayamada, Koshiro Sonomoto, et al.. (2021). Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus. Lara D. Veeken. 61(9). 3614–3626. 17 indexed citations

13.

Inoue, Yoshino, Shingo Nakayamada, Satoshi Kubo, et al.. (2021). T helper cells expressing fractalkine receptor and bearing T follicular helper 1-like cell functions in patients with IgG4-related disease. Lara D. Veeken. 61(9). 3854–3863. 7 indexed citations

14.

Miyazaki, Yusuke, Shingo Nakayamada, Kazuhisa Nakano, et al.. (2021). POS0221 COMPARISON OF TOFACITINIB AND BARICITINIB BY INVERSE PROBABILITY OF TREATMENT WEIGHTING ANALYSES BASED ON PROPENSITY SCORE IN PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL CLINICAL PRACTICE. Annals of the Rheumatic Diseases. 80. 329–329. 1 indexed citations

15.

Miyagawa, Ippei, Kazuhisa Nakano, Shingo Nakayamada, et al.. (2020). The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus. International Journal of Rheumatic Diseases. 23(4). 549–558. 10 indexed citations

16.

Nakano, Kazuhisa, et al.. (2020). Stimulator of Interferon Genes-associated Vasculopathy with an Onset in Infancy Diagnosed after the Development of Atypical Pulmonary Lesions During Treatment as Juvenile Idiopathic Arthritis. Internal Medicine. 60(7). 1109–1114. 3 indexed citations

17.

He, Hao, Shingo Nakayamada, Kaoru Yamagata, et al.. (2020). Conversion of T Follicular Helper Cells to T Follicular Regulatory Cells by Interleukin‐2 Through Transcriptional Regulation in Systemic Lupus Erythematosus. Arthritis & Rheumatology. 73(1). 132–142. 55 indexed citations

18.

Miyagawa, Ippei, Kazuhisa Nakano, Shingo Nakayamada, et al.. (2018). Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus. International Journal of Rheumatic Diseases. 22(3). 434–442. 15 indexed citations

19.

Kaneko, Eiji, et al.. (2018). Proposal of EMTP Surge Analysis Model for a Power Cable through a Transmission Tower. IEEJ Transactions on Power and Energy. 138(9). 791–798. 1 indexed citations

20.

Matsuwaki, Yoshinori, Thomas A. White, Kinya Hotta, et al.. (2007). Aspartate Protease From Alternaria Induced Cytokine Production, And Calcium Signaling In Human Airway Epithelial Cells Through A Protease-activated Receptor-2 (par-2). Journal of Allergy and Clinical Immunology. 119(1). S137–S137. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact